First Horizon Advisors, Inc. Bio Rad Laboratories, Inc. Transaction History

First Horizon Advisors, Inc.

  • $3.58 Billion
  • Q3 2024

A detailed history of First Horizon Advisors, Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 250 shares of BIO stock, worth $84,620. This represents 0.0% of its overall portfolio holdings.

Number of Shares
250
Previous 271 7.75%
Holding current value
$84,620
Previous $74,000 12.16%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$263.97 - $344.64 $5,543 - $7,237
-21 Reduced 7.75%
250 $83,000
Q2 2024

Jul 19, 2024
SELL
$268.26 - $339.48 $34,605 - $43,792
-129 Reduced 32.25%
271 $74,000
Q1 2024

Apr 26, 2024
BUY
$304.11 - $351.99 $1,520 - $1,759
5 Added 1.27%
400 $138,000
Q4 2023

Feb 06, 2024
BUY
$269.37 - $365.04 $7,003 - $9,491
26 Added 7.05%
395 $127,000
Q3 2023

Oct 27, 2023
BUY
$350.25 - $422.63 $3,852 - $4,648
11 Added 3.07%
369 $132,000
Q2 2023

Aug 03, 2023
SELL
$359.49 - $486.4 $10,065 - $13,619
-28 Reduced 7.25%
358 $135,000
Q1 2023

May 15, 2023
BUY
$418.69 - $503.0 $1,256 - $1,509
3 Added 0.78%
386 $184,000
Q4 2022

Feb 10, 2023
BUY
$351.71 - $456.01 $9,847 - $12,768
28 Added 7.89%
383 $161,000
Q3 2022

Nov 09, 2022
SELL
$412.59 - $563.26 $68,902 - $94,064
-167 Reduced 31.99%
355 $147,000
Q2 2022

Aug 02, 2022
BUY
$463.67 - $597.16 $146,983 - $189,299
317 Added 154.63%
522 $258,000
Q1 2022

May 10, 2022
SELL
$524.57 - $735.42 $19,933 - $27,945
-38 Reduced 15.64%
205 $115,000
Q4 2021

Feb 09, 2022
BUY
$708.84 - $794.68 $16,303 - $18,277
23 Added 10.45%
243 $183,000
Q3 2021

Nov 15, 2021
SELL
$657.71 - $825.77 $26,308 - $33,030
-40 Reduced 15.38%
220 $164,000
Q3 2021

Nov 09, 2021
BUY
$657.71 - $825.77 $36,174 - $45,417
55 Added 26.83%
260 $193,000
Q1 2021

May 11, 2021
BUY
$547.01 - $662.35 $2,735 - $3,311
5 Added 2.5%
205 $117,000
Q2 2020

Jul 31, 2020
SELL
$334.87 - $493.06 $8,371 - $12,326
-25 Reduced 11.11%
200 $90,000
Q2 2019

Aug 05, 2019
SELL
$286.93 - $312.59 $3,730 - $4,063
-13 Reduced 5.46%
225 $0
Q1 2019

Apr 26, 2019
BUY
$224.3 - $317.41 $2,915 - $4,126
13 Added 5.78%
238 $0
Q3 2018

Nov 05, 2018
BUY
$289.28 - $326.15 $65,087 - $73,383
225 New
225 $0
Q3 2018

Nov 05, 2018
SELL
$289.28 - $326.15 $65,087 - $73,383
-225 Closed
0 $0
Q2 2017

Aug 14, 2017
BUY
N/A
225
225 $0

Others Institutions Holding BIO

# of Institutions
457
Shares Held
18.2M
Call Options Held
19.5K
Put Options Held
13.9K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.34B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email